Archive · 29 Jul 2026
Delhi HC seeks Centre, FSSAI's stand on artificial sweeteners' health impact
The Delhi High Court has asked the central government and the Food Safety and Standards Authority of India (FSSAI) to respond to a petition about the health risks of artificial sweeteners.
The petition, filed by the Indian Sugar & Bio-energy Manufacturers Association, says that scientific studies show these sweeteners might cause serious health problems like cancer, heart disease, and issues with the brain and gut.
The court wants the FSSAI to study these risks and give clear warnings to the public, especially for children, pregnant women, and people with diabetes.
The next hearing is on September 29.
Delhi High Court seeks Centre and FSSAI's response on petition about artificial sweeteners' health risks.
Petition filed by Indian Sugar & Bio-energy Manufacturers Association cites potential long-term health implications.
Court wants comprehensive evaluation and public advisories on artificial sweeteners' health impacts.
Key concerns include carcinogenicity, metabolic disorders, neurological effects, and cardiovascular disease.
Next hearing scheduled for September 29.
- Who
- Delhi High Court, Centre, FSSAI, Indian Sugar & Bio-energy Manufacturers Association
- What
- Petition regarding health implications of artificial sweeteners
- When
- Notice issued on July 23, next hearing on September 29
- Where
- Delhi High Court
- Why
- To seek comprehensive evaluation and public advisories on the health impacts of artificial sweeteners
Indian Sugar & Bio-energy Manufacturers Association
Centre and FSSAI
Health Implications
Indian Sugar & Bio-energy Manufacturers Association
Artificial sweeteners have potential long-term health risks including carcinogenicity, metabolic disorders, and neurological effects.
Centre and FSSAI
No explicit stance yet, as the Centre and FSSAI have been asked to provide their replies.
- Petitioner
- Indian Sugar & Bio-energy Manufacturers Association (ISMA)
- Court
- Delhi High Court
- Date of Notice
- July 23
- Next Hearing
- September 29
- Key Concerns
- Carcinogenicity, metabolic disorders, neurological effects, cardiovascular disease, gut microbiome alterations